Dow Down 0.92% Nasdaq Down 0.83%

Exelixis, Inc. (EXEL)

-NasdaqGS
1.59 0.01(0.62%) Oct 22, 4:00PM EDT
Prev Close:1.60
Open:1.60
Bid:1.56 x 300
Ask:1.61 x 500
1y Target Est:2.75
Beta:2.46
Next Earnings Date: 4-Nov-14EXEL Earnings announcement
Day's Range:1.57 - 1.62
52wk Range:1.35 - 8.41
Volume:1,280,920
Avg Vol (3m):4,422,760
Market Cap:310.22M
P/E (ttm):N/A
EPS (ttm):-1.52
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for EXEL

Comparison

Symbol% ChgMkt Cap
EXELDown 0.62%310.22M
AZN86.87B
GSK106.67B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):14.67
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-1.48
Quarterly EPS Est (Sep-14) :-0.37
Mean Recommendation*:2.7
PEG Ratio (5 yr expected):0.04

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Exelixis, Inc., a biotechnology company, develops small molecule therapies for the treatment of cancer in the United States. The company focuses primarily on developing and commercializing COMETRIQ, an inhibitor of multiple receptor tyrosine kinas... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback